Integrated Filing — IndAS

General information about company
Scrip Code	538666
NSE Symbol	SHARDACROP
MSEI Symbol	NOTLISTED
ISIN	INE221J01015
Name of company	Sharda Cropchem Limited
Type of company	Main Board
Class of security	Equity
Date of start of financial year	01-Apr-2024
Date of end of financial year	31-Mar-2025
Date of board meeting when results were approved	14-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange	05-May-2025
Description of presentation currency	INR (in Actuals)
Reporting Type	Quarterly
Reporting Quarter	Fourth quarter
Nature of report standalone or consolidated	Consolidated
Whether results are audited or unaudited for the quarter ended	Audited
Whether results are audited or unaudited for the Year to date for current period ended/year ended	Audited
Segment Reporting	Multi segment
Description of single segment
Start date and time of board meeting	14-May-2025   12:15:00
End date and time of board meeting	14-May-2025   14:30:00
Whether cash flow statement is applicable on company	Yes
Type of cash flow statement	Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification	Not applicable

Financial Results Ind-AS
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
Part I	Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1	Income
	Revenue from operations	18285252000	43198530000
	Other income	252346000	595345000
	Total income	18537598000	43793875000
2	Expenses
(a)	Cost of materials consumed	8281978000	17763329000
(b)	Purchases of stock-in-trade	3040704000	13112150000
(c)	Changes in inventories of finished goods, work-in-progress and stock-in-trade	1522254000	-594943000
(d)	Employee benefit expense	182253000	520215000
(e)	Finance costs	4073000	21058000
(f)	Depreciation, depletion and amortisation expense	718952000	2746639000
(f)	Other Expenses
1	Foreign Exchange (Gain) / Loss	-105316000	179002000
2	Other Expenses	2331635000	6263036000
	Total other expenses	2226319000	6442038000
	Total expenses	15976533000	40010486000
3	Total profit before exceptional items and tax	2561065000	3783389000
4	Exceptional items	0	0
5	Total profit before tax	2561065000	3783389000
6	Tax expense
7	Current tax	305218000	535011000
8	Deferred tax	219821000	204202000
9	Total tax expenses	525039000	739213000
10	Net movement in regulatory deferral account balances related to profit or loss and the related deferred tax movement	0	0
11	Net Profit Loss for the period from continuing operations	2036026000	3044176000
12	Profit (loss) from discontinued operations before tax	0	0
13	Tax expense of discontinued operations	0	0
14	Net profit (loss) from discontinued operation after tax	0	0
15	Share of profit (loss) of associates and joint ventures accounted for using equity method	0	0
16	Total profit (loss) for period	2036026000	3044176000
17	Other comprehensive income net of taxes	91603000	143582000
18	Total Comprehensive Income for the period	2127629000	3187758000
19	Total profit or loss, attributable to
	Profit or loss, attributable to owners of parent	2035672000	3043783000
	Total profit or loss, attributable to non-controlling interests	354000	354000
20	Total Comprehensive income for the period attributable to
	Comprehensive income for the period attributable to owners of parent	2127285000	3187387000
	Total comprehensive income for the period attributable to owners of parent non-controlling interests	344000	371000
21	Details of equity share capital
	Paid-up equity share capital	902205000	902205000
	Face value of equity share capital	10	10
27	Details of debt securities
22	Reserves excluding revaluation reserve		0
23	Earnings per share
i	Earnings per equity share for continuing operations
	Basic earnings (loss) per share from continuing operations	22.57	33.74
	Diluted earnings (loss) per share from continuing operations	22.57	33.74
ii	Earnings per equity share for discontinued operations
	Basic earnings (loss) per share from discontinued operations	0	0
	Diluted earnings (loss) per share from discontinued operations	0	0
ii	Earnings per equity share
	Basic earnings (loss) per share from continuing and discontinued operations	22.57	33.74
	Diluted earnings (loss) per share from continuing and discontinued operations	22.57	33.74
24	Debt equity ratio
25	Debt service coverage ratio
26	Interest service coverage ratio
27	Disclosure of notes on financial results		1. The aforesaid financial results have been reviewed by the Audit Committee and approved by the Board of Directors at their meeting held on May 14, 2025. The statutory auditors have expressed an unmodified opinion on these results. n n2. The financial results for all the periods presented have been prepared in accordance with the recognition and measurement principles of Ind AS notified under the Companies Indian Accounting Standards Rules, 2015 as amended from time to time. n n3. The Board of Directors have recommended final dividend of Rs.6 per equity share of Rs.10 each fully paid up for the financial year 2024 2025, subject to the approval of shareholders at the ensuing Annual General Meeting. n n4. The figures for the three months ended March 31, 2025 and March 31, 2024 are the balancing figures between the audited figures in respect of the full financial year ended on those dates and the published year to date figures upto December 31, 2024 and December 31, 2023 respectively. n n5. Other expenses income includes loss gain on fair valuation of investments as under n nParticulars Three months ended Year ended n March 31, 2025 March 31,2025 n n Loss Gain on 287.35 805.37 nfair valuation nof investments n n6. One of the segments of the Group, viz Agrochemicals, is seasonal in nature and the performance can be impacted by cropping pattern and weather conditions across the globe. Accordingly, quarterly figures are not representative of the other quarters and full years performance. n n7. The Company has 37 subsidiaries including 10 step down subsidiaries of one of the subsidiary as on March 31, 2025, excludes 2 subsidiaries closed during the year. n n8. Figures for the previous period year have been regrouped rearranged, wherever considered necessary to conform to the current period years classification.

Remarks
Debt equity ratio
Debt service coverage ratio
Interest service coverage ratio

Statement of Asset and Liabilities
Particulars		Year ended (dd-mm-yyyy)
Date of start of reporting period		01-Apr-2024
Date of end of reporting period		31-Mar-2025
Whether results are audited or unaudited		Audited
Nature of report standalone or consolidated		Consolidated
	Assets
1	Non-current assets
	Property, plant and equipment	101411000
	Capital work-in-progress	0
	Investment property	0
	Goodwill	0
	Other intangible assets	7402425000
	Intangible assets under development	2913824000
	Biological assets other than bearer plants	0
	Investments accounted for using equity method	0
	Non-current financial assets
	Non-current investments	0
	Trade receivables, non-current	0
	Loans, non-current	0
	Other non-current financial assets	217546000
	Total non-current financial assets	217546000
	Deferred tax assets (net)	115593000
	Other non-current assets	633763000
	Total non-current assets	11384562000
2	Current assets
	Inventories	9719308000
	Current financial asset
	Current investments	2943274000
	Trade receivables, current	19554418000
	Cash and cash equivalents	1272129000
	Bank balance other than cash and cash equivalents	931358000
	Loans, current	0
	Other current financial assets	475167000
	Total current financial assets	25176346000
	Current tax assets (net)	0
	Other current assets	968300000
	Total current assets	35863954000
3	Non-current assets classified as held for sale	0
4	Regulatory deferral account debit balances and related deferred tax Assets	0
	Total assets	47248516000
	Equity and liabilities
1	Equity
	Equity attributable to owners of parent
	Equity share capital	902205000
	Other equity	24103484000
	Total equity attributable to owners of parent	25005689000
	Non controlling interest	4132000
	Total equity	25009821000
2	Liabilities
	Non-current liabilities
	Non-current financial liabilities
	Borrowings, non-current	0
	Trade payables, non-current
	(A) Total outstanding dues of micro enterprises and small enterprises	0
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	0
	Total Trade payable	0
	Other non-current financial liabilities	630138000
	Total non-current financial liabilities	630138000
	Provisions, non-current	13084000
	Deferred tax liabilities (net)	1738051000
	Deferred government grants, Non-current	0
	Other non-current liabilities	0
	Total non-current liabilities	2381273000
	Current liabilities
	Current financial liabilities
	Borrowings, current	0
	Trade payables, current
	(A) Total outstanding dues of micro enterprises and small enterprises	50929000
	(B) Total outstanding dues of creditors other than micro enterprises and small enterprises	13051103000
	Total Trade payable	13102032000
	Other current financial liabilities	5090436000
	Total current financial liabilities	18192468000
	Other current liabilities	1046984000
	Provisions, current	575624000
	Current tax liabilities (Net)	42346000
	Deferred government grants, Current	0
	Total current liabilities	19857422000
3	Liabilities directly associated with assets in disposal group classified as held for sale	0
4	Regulatory deferral account credit balances and related deferred tax liability	0
	Total liabilities	22238695000
	Total equity and liabilites	47248516000
	Disclosure of notes on assets and liabilities

Format for Reporting Segmenet wise Revenue, Results and Capital Employed along with the company results
Particulars		3 months/ 6 month ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period		01-Jan-2025	01-Apr-2024
Date of end of reporting period		31-Mar-2025	31-Mar-2025
Whether accounts are audited or unaudited		Audited	Audited
Nature of report standalone or consolidated		Consolidated	Consolidated
1	Segment Revenue (Income)
	(net sale/income from each segment should be disclosed)
1	Agrochemicals	16907722000	37729693000
2	Non-agrochemicals	1377530000	5468837000
	Total Segment Revenue	18285252000	43198530000
	Less: Inter segment revenue	0	0
	Revenue from operations	18285252000	43198530000
2	Segment Result
	Profit (+) / Loss (-) before tax and interest from each segment
1	Agrochemicals	2034813000	2300275000
2	Non-agrochemicals	386282000	1264305000
	Total Profit before tax	2421095000	3564580000
	i. Finance cost	4073000	4073000
	ii. Other Unallocable Expenditure net off Unallocable income	-144043000	-144043000
	Profit before tax	2561065000	3783389000
3	(Segment Asset - Segment Liabilities)
	Segment Asset
1	Agrochemicals	38943682000	38943682000
2	Non-agrochemicals	1661012000	1661012000
	Total Segment Asset	40604694000	40604694000
	Un-allocable Assets	6643822000	6643822000
	Net Segment Asset	47248516000	47248516000
4	Segment Liabilities
	Segment Liabilities
1	Agrochemicals	19411490000	19411490000
2	Non-agrochemicals	914324000	914324000
	Total Segment Liabilities	20325814000	20325814000
	Un-allocable Liabilities	1912881000	1912881000
	Net Segment Liabilities	22238695000	22238695000
	Disclosure of notes on segments	Textual Information(2)

Text Block

Textual Information(2)

Note n nThe activities of the Group are divided into two business segments viz. Agrochemicals, Non agrochemicals representing Conveyor Belts, Dyes and Dye Intermediates and General Chemicals. These segments form the basis for management control and therefore the basis for monitoring. n nBased on the management approach as defined in Ind AS 108 Operating Segments the Chief Operating Decision Maker evaluates the Groups performance and allocates resources based on an analysis of various performance indicators by business segments and segment information is presented accordingly.

Other Comprehensive Income
Particulars		3 months/ 6 months ended (dd-mm-yyyy)	Year to date figures for current period ended (dd-mm-yyyy)
A	Date of start of reporting period	01-Jan-2025	01-Apr-2024
B	Date of end of reporting period	31-Mar-2025	31-Mar-2025
C	Whether results are audited or unaudited	Audited	Audited
D	Nature of report standalone or consolidated	Consolidated	Consolidated
	Other comprehensive income [Abstract]
1	Amount of items that will not be reclassified to profit and loss
1	Items that will not be reclassified to profit or loss	1677000	998000
	Total Amount of items that will not be reclassified to profit and loss	1677000	998000
2	Income tax relating to items that will not be reclassified to profit or loss	436000	251000
3	Amount of items that will be reclassified to profit and loss
1	Items that will be reclassified to profit or loss	90362000	142835000
	Total Amount of items that will be reclassified to profit and loss	90362000	142835000
4	Income tax relating to items that will be reclassified to profit or loss	0	0
5	Total Other comprehensive income	91603000	143582000

Cash flow statement, indirect
Particulars				Year ended (dd-mm-yyyy)
A	Date of start of reporting period			2024-04-01
B	Date of end of reporting period			2025-03-31
C	Whether results are audited or unaudited			Audited
D	Nature of report standalone or consolidated			Consolidated
Part I	Blue color marked fields are non-mandatory.
	Statement of cash flows
	Cash flows from used in operating activities
	Profit before tax			3783389000
	Adjustments for reconcile profit (loss)
	Adjustments for finance costs			21058000
	Adjustments for decrease (increase) in inventories			197092000
	Adjustments for decrease (increase) in trade receivables, current			-4562807000
	Adjustments for decrease (increase) in trade receivables, non-current			0
	Adjustments for decrease (increase) in other current assets			-234546000
	Adjustments for decrease (increase) in other non-current assets			53016000
	Adjustments for other financial assets, non-current			355000
	Adjustments for other financial assets, current			562000
	Adjustments for other bank balances			0
	Adjustments for increase (decrease) in trade payables, current			4015362000
	Adjustments for increase (decrease) in trade payables, non-current			0
	Adjustments for increase (decrease) in other current liabilities			0
	Adjustments for increase (decrease) in other non-current liabilities			0
	Adjustments for depreciation and amortisation expense			2746639000
	Adjustments for impairment loss reversal of impairment loss recognised in profit or loss			680827000
	Adjustments for provisions, current			0
	Adjustments for provisions, non-current			-184586000
	Adjustments for other financial liabilities, current			410143000
	Adjustments for other financial liabilities, non-current			0
	Adjustments for unrealised foreign exchange losses gains			-59294000
	Adjustments for dividend income			0
	Adjustments for interest income			275805000
	Adjustments for share-based payments			0
	Adjustments for fair value losses (gains)			-80537000
	Adjustments for undistributed profits of associates			0
	Other adjustments for which cash effects are investing or financing cash flow			0
	Other adjustments to reconcile profit (loss)			-66046000
	Other adjustments for non-cash items			-98992000
	Share of profit and loss from partnership firm or association of persons or limited liability partnerships			0
	Total adjustments for reconcile profit (loss)			2562441000
	Net cash flows from (used in) operations			6345830000
	Dividends received			0
	Interest paid			0
	Interest received			0
	Income taxes paid (refund)			309609000
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) operating activities			6036221000
	Cash flows from used in investing activities
	Cash flows from losing control of subsidiaries or other businesses			0
	Cash flows used in obtaining control of subsidiaries or other businesses			0
	Other cash receipts from sales of equity or debt instruments of other entities			0
	Other cash payments to acquire equity or debt instruments of other entities			0
	Other cash receipts from sales of interests in joint ventures			0
	Other cash payments to acquire interests in joint ventures			0
	Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships			0
	Cash payment for investment in partnership firm or association of persons or limited liability partnerships			0
	Proceeds from sales of property, plant and equipment			0
	Purchase of property, plant and equipment			1680000
	Proceeds from sales of investment property			0
	Purchase of investment property			0
	Proceeds from sales of intangible assets			0
	Purchase of intangible assets			3928949000
	Proceeds from sales of intangible assets under development			0
	Purchase of intangible assets under development			0
	Proceeds from sales of goodwill			0
	Purchase of goodwill			0
	Proceeds from biological assets other than bearer plants			0
	Purchase of biological assets other than bearer plants			0
	Proceeds from government grants			0
	Proceeds from sales of other long-term assets			0
	Purchase of other long-term assets			0
	Cash advances and loans made to other parties			0
	Cash receipts from repayment of advances and loans made to other parties			0
	Cash payments for future contracts, forward contracts, option contracts and swap contracts			0
	Cash receipts from future contracts, forward contracts, option contracts and swap contracts			0
	Dividends received			54609000
	Interest received			61121000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			-1285705000
	Net cash flows from (used in) investing activities	-5100604000
	Cash flows from used in financing activities
	Proceeds from changes in ownership interests in subsidiaries			0
	Payments from changes in ownership interests in subsidiaries			0
	Proceeds from issuing shares			0
	Proceeds from issuing other equity instruments			0
	Payments to acquire or redeem entity's shares			0
	Payments of other equity instruments			0
	Proceeds from exercise of stock options			0
	Proceeds from issuing debentures notes bonds etc			0
	Proceeds from borrowings			0
	Repayments of borrowings			33751000
	Payments of lease liabilities			81000000
	Dividends paid			552857000
	Interest paid			11707000
	Income taxes paid (refund)			0
	Other inflows (outflows) of cash			0
	Net cash flows from (used in) financing activities			-679315000
	Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes			256302000
	Effect of exchange rate changes on cash and cash equivalents
	Effect of exchange rate changes on cash and cash equivalents			142952000
	Net increase (decrease) in cash and cash equivalents			399254000
	Cash and cash equivalents cash flow statement at beginning of period			872875000
	Cash and cash equivalents cash flow statement at end of period			1272129000